- Home
- MREO vs EEA Comparison
MREO vs EEA Comparison
Compare MREO & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | EEA |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United Kingdom | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 71.6M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | EEA |
|---|---|---|
| Price | $0.35 | $9.65 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.13 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 30.7K |
| Earning Date | 03-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $8.11 |
| 52 Week High | $2.94 | $11.43 |
Technical Indicators
Market Signals| Indicator | MREO | EEA |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 19.43 |
| Support Level | $0.20 | N/A |
| Resistance Level | $0.42 | $11.04 |
| Average True Range (ATR) | 0.03 | 0.31 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 22.62 | 1.35 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.